RESUMEN
Zinc (Zn) is an important dietary nutrient for the optimum growth performance, feed efficiency, normal metabolism, and fish health. Unfortunately, Zn requirement for mori (Cirrhinus mrigala) is not available. This experiment was designed to assess the impacts of Zn-gluconate levels on growth performance, feed utilization, mineral composition, and enzyme activities of mori and determines the optimum requirement of Zn-gluconate for this species. For this purpose, seven isonitrogenous (29.18%) and isolipidic (10.71%) purified diets were formulated with graded Zn-gluconate levels (0, 10, 20, 30, 40, 50, and 60 mg/kg). A total of 525 juveniles (4.30 ± 0.13 g) were distributed in 21 tanks. All treatments were assessed in triplicates. At the end of the trial (90 days), a progressive increase in final weight (FW) was observed in mori fed with 0-40 mg/kg of Zn-gluconate, remained constant at 50 mg/kg of Zn-gluconate, and significantly decreased at 60 mg/kg of Zn-gluconate. Similarly, weight gain and specific growth rate followed a similar pattern, while weight gain% increased till 40 mg/kg of Zn-gluconate. However, further increase (40-60 mg/kg) had a non-significant effect on weight gain%. Diet supplemented with 40 mg/kg of Zn-gluconate resulted in optimum values for feed intake and feed conversion ratio. Supplementation of Zn-gluconate did not affect dry matter, crude fat, and crude ash at all graded levels. However, whole body crude protein was significant in response to Zn-gluconate supplementation. Furthermore, Zn-gluconate absorption enhanced from 0 to 40 mg/kg of Zn-gluconate and remained constant afterward. Whole body mineral activity also followed a similar pattern. Overall, Zn-gluconate supplementation enhanced (P < 0.05) mineral activity in all parts of the tested parts of mori, including bones, scales, skin, eyes, heart, liver, and kidney. Moreover, the highest (P < 0.05) mineral activity in the skin, heart, liver, and kidney was observed in 60 mg/kg of Zn-gluconate. Supplementation of Zn-gluconate significantly increased the activity of alkaline phosphatase while it reduced thiobarbituric acid reactive substance contents of mori. The optimal dietary requirement of Zn-gluconate was recorded as 43.86 mg/kg through broken-line regression for maximum weight gain% of mori juveniles. Conclusively, 40 mg/kg of Zn-gluconate supplementation significantly enhanced the health of C. mrigala. However, a further increase in Zn-gluconate supplementation from 40 to 60 mg/kg did not significantly improve the above-mentioned parameters.
RESUMEN
The spread of SARS-COVID 19 infection has resulted in accelerated efforts at development and dissemination of vaccines throughout the globe. These vaccines have different mechanisms of actions and their efficacy and side effects are being monitored. There have been rare reports in literature of thyroid dysfunction after COVID-19 vaccine administration. Sub-acute thyroiditis is one such complication which can arise as a rare side-effect of vaccination. This has also been reported as a symptom of COVID-19 infection. Clinical features include fever, neck pain, palpitations and weight loss. We report sub-acute thyroiditis in a 50-year-old male who presented with symptoms suggestive of thyroid abnormality one day after receiving the inactivated COVID-19 vaccine (CoronaVac Sinovac-Biotech Ltd).
